These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23516552)

  • 1. High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.
    Song L; Li X; Jayandharan GR; Wang Y; Aslanidi GV; Ling C; Zhong L; Gao G; Yoder MC; Ling C; Tan M; Srivastava A
    PLoS One; 2013; 8(3):e58757. PubMed ID: 23516552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant self-complementary adeno-associated virus serotype vector-mediated hematopoietic stem cell transduction and lineage-restricted, long-term transgene expression in a murine serial bone marrow transplantation model.
    Maina N; Han Z; Li X; Hu Z; Zhong L; Bischof D; Weigel-Van Aken KA; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2008 Apr; 19(4):376-83. PubMed ID: 18370591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression.
    Maina N; Zhong L; Li X; Zhao W; Han Z; Bischof D; Aslanidi G; Zolotukhin S; Weigel-Van Aken KA; Rivers AE; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2008 Apr; 19(4):365-75. PubMed ID: 18399730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
    Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A
    J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.
    Song L; Kauss MA; Kopin E; Chandra M; Ul-Hasan T; Miller E; Jayandharan GR; Rivers AE; Aslanidi GV; Ling C; Li B; Ma W; Li X; Andino LM; Zhong L; Tarantal AF; Yoder MC; Wong KK; Tan M; Chatterjee S; Srivastava A
    Cytotherapy; 2013 Aug; 15(8):986-98. PubMed ID: 23830234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing.
    Ling C; Bhukhai K; Yin Z; Tan M; Yoder MC; Leboulch P; Payen E; Srivastava A
    Sci Rep; 2016 Oct; 6():35495. PubMed ID: 27759036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.
    Sayroo R; Nolasco D; Yin Z; Colon-Cortes Y; Pandya M; Ling C; Aslanidi G
    Gene Ther; 2016 Jan; 23(1):18-25. PubMed ID: 26270885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2.
    Kauss MA; Smith LJ; Zhong L; Srivastava A; Wong KK; Chatterjee S
    Hum Gene Ther; 2010 Sep; 21(9):1129-36. PubMed ID: 20486772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors.
    Moreau-Gaudry F; Xia P; Jiang G; Perelman NP; Bauer G; Ellis J; Surinya KH; Mavilio F; Shen CK; Malik P
    Blood; 2001 Nov; 98(9):2664-72. PubMed ID: 11675336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5.
    Zhong L; Li W; Li Y; Zhao W; Wu J; Li B; Maina N; Bischof D; Qing K; Weigel-Kelley KA; Zolotukhin I; Warrington KH; Li X; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2006 Mar; 17(3):321-33. PubMed ID: 16544981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells.
    Wang XS; Yoder MC; Zhou SZ; Srivastava A
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12416-20. PubMed ID: 8618912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
    Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
    J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy.
    Pandya J; Ortiz L; Ling C; Rivers AE; Aslanidi G
    Immunol Cell Biol; 2014 Feb; 92(2):116-23. PubMed ID: 24217810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
    Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector.
    Uchida N; Washington KN; Lap CJ; Hsieh MM; Tisdale JF
    Mol Ther; 2011 Jan; 19(1):133-9. PubMed ID: 20940706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.
    Kay CN; Ryals RC; Aslanidi GV; Min SH; Ruan Q; Sun J; Dyka FM; Kasuga D; Ayala AE; Van Vliet K; Agbandje-McKenna M; Hauswirth WW; Boye SL; Boye SE
    PLoS One; 2013; 8(4):e62097. PubMed ID: 23637972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.
    Cheng B; Ling C; Dai Y; Lu Y; Glushakova LG; Gee SW; McGoogan KE; Aslanidi GV; Park M; Stacpoole PW; Siemann D; Liu C; Srivastava A; Ling C
    Gene Ther; 2012 Apr; 19(4):375-84. PubMed ID: 21776025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle.
    Qiao C; Zhang W; Yuan Z; Shin JH; Li J; Jayandharan GR; Zhong L; Srivastava A; Xiao X; Duan D
    Hum Gene Ther; 2010 Oct; 21(10):1343-8. PubMed ID: 20497037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Transduction of Human Hematopoietic Stem Cells by AAV6 Vectors: Implications in Gene Therapy and Genome Editing.
    Yang H; Qing K; Keeler GD; Yin L; Mietzsch M; Ling C; Hoffman BE; Agbandje-McKenna M; Tan M; Wang W; Srivastava A
    Mol Ther Nucleic Acids; 2020 Jun; 20():451-458. PubMed ID: 32276210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.